Incyte Appoints Suky Upadhyay as New EVP and Chief Financial Officer

Key Facts

1Incyte announced the appointment of Suketu (Suky) Upadhyay as EVP and CFO, effective May 4, 2026.

2Upadhyay will oversee strategic financial planning, capital allocation, and investor relations.

Incyte has announced the appointment of Suketu (Suky) Upadhyay as Executive Vice President and Chief Financial Officer, effective May 4, 2026. Upadhyay will be responsible for leading the company's global finance organization, overseeing strategic financial planning, capital allocation, and investor relations. The appointment aims to leverage his extensive financial leadership experience gained at major healthcare firms, including Zimmer Biomet and Bristol Myers Squibb. In his new role, he is expected to drive operational efficiency and support the company's long-term growth objectives. This leadership transition reflects Incyte's commitment to strengthening its C-suite with seasoned industry veterans. Market participants typically monitor such executive changes for potential shifts in corporate strategy or capital management priorities.